Claire Corot

Articles in Scholarly Journals [Incomplete List]

  1. Effect of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) on human monocyte-macrophages in vitro
    Biomaterials, vol. 28, no. 9, pp. 1629–1642, 2007
  2. MR imaging of antigen-induced arthritis with a new, folate receptor-targeted contrast agent
    Contrast Media & Molecular Imaging, vol. 2, no. 2, pp. 72–81, 2007
  3. ERRATUM
    Fundamental & Clinical Pharmacology, vol. 21, no. 3, pp. 335–335, 2007
  4. Contrast-Enhanced Magnetic Resonance Angiography
    Investigative Radiology, vol. 42, no. 9, pp. 622–628, 2007
  5. Interaction of Functionalized Superparamagnetic Iron Oxide Nanoparticles with Brain Structures
    Journal of Pharmacology and Experimental Therapeutics, vol. 318, no. 1, pp. 108–116, 2006
  6. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review
    Fundamental and Clinical Pharmacology, vol. 20, no. 6, pp. 563–576, 2006
  7. Magnetic resonance imaging of experimental atherosclerotic plaque: Comparison of two ultrasmall superparamagnetic particles of iron oxide
    Journal of Magnetic Resonance Imaging, vol. 24, no. 2, pp. 388–393, 2006
  8. Multi-Slice DCE-MRI Data Using P760 Distinguishes Between Metastatic and Non-Metastatic Rodent Prostate Tumors
    Magnetic Resonance Materials in Physics, Biology and Medicine, vol. 19, no. 1, pp. 15–21, 2006
  9. Recent advances in iron oxide nanocrystal technology for medical imaging?
    Advanced Drug Delivery Reviews, vol. 58, no. 14, pp. 1471–1504, 2006
  10. Discrimination of Myocardial Acute and Chronic (Scar) Infarctions on Delayed Contrast Enhanced Magnetic Resonance Imaging With Intravascular Magnetic Resonance Contrast Media
    Journal of the American College of Cardiology, vol. 48, no. 10, pp. 1961–1968, 2006
  11. Magnetic resonance characterization of tumor microvessels in experimental breast tumors using a slow clearance blood pool contrast agent (carboxymethyldextran-A2-Gd-DOTA) with histopathological correlation
    European Radiology, vol. 15, no. 11, pp. 2268–2275, 2005
  12. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning
    European Radiology, vol. 16, no. 3, pp. 738–745, 2005
  13. Optimization of a blood pool contrast agent injection protocol for MR angiography
    Journal of Magnetic Resonance Imaging, vol. 21, no. 5, pp. 611–619, 2005
  14. Distribution of gadomelitol in a human breast tumor model in mice
    Magnetic Resonance Materials in Physics, Biology and Medicine, vol. 18, no. 3, pp. 138–143, 2005
  15. Renal Functional Contrast-Enhanced Magnetic Resonance Imaging
    Investigative Radiology, vol. 40, no. 5, pp. 295–305, 2005
  16. How to Compare the Efficiency of Albumin-Bound and Nonalbumin-Bound Contrast Agents In Vivo
    Investigative Radiology, vol. 40, no. 9, pp. 565–573, 2005
  17. Allergy-like reactions to iodinated contrast agents. A critical analysis
    Fundamental and Clinical Pharmacology, vol. 19, no. 3, pp. 263–281, 2005
  18. Migration of Iron Oxide-labeled Human Hematopoietic Progenitor Cells in a Mouse Model: In Vivo Monitoring with 1.5-T MR Imaging Equipment
    Radiology, vol. 234, no. 1, pp. 197–205, 2005
  19. Detection of Synovial Macrophages in an Experimental Rabbit Model of Antigen-induced Arthritis: Ultrasmall Superparamagnetic Iron Oxide-enhanced MR Imaging
    Radiology, vol. 233, no. 1, pp. 149–157, 2004
  20. Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles
    Investigative Radiology, vol. 39, no. 1, pp. 56–63, 2004
  21. Prophylaxis of Iodinated Contrast Media-Induced Nephropathy
    Investigative Radiology, vol. 39, no. 3, pp. 155–170, 2004
  22. Dark Lumen Magnetic Resonance Colonography in a Rodent Polyp Model
    Investigative Radiology, vol. 39, no. 12, pp. 723–727, 2004
  23. Macrophage Imaging in Central Nervous System and in Carotid Atherosclerotic Plaque Using Ultrasmall Superparamagnetic Iron Oxide in Magnetic Resonance Imaging
    Investigative Radiology, vol. 39, no. 10, pp. 619–625, 2004
  24. New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors
    Magnetic Resonance in Medicine, vol. 51, no. 3, pp. 487–494, 2004
  25. Three-dimensional navigator coronary MRA with the aid of a blood pool agent in pigs: Improved image quality with inclusion of the contrast agent first-pass
    Journal of Magnetic Resonance Imaging, vol. 18, no. 4, pp. 502–506, 2003
  26. Assessment of normal, inflammatory, and tumor-bearing lymph nodes with contrast-enhanced interstitial magnetic resonance lymphography: Preliminary results in rabbits
    Journal of Magnetic Resonance Imaging, vol. 18, no. 3, pp. 328–335, 2003
  27. Investigative Radiology, vol. 38, no. 1, pp. 34–43, 2003
  28. Investigative Radiology, vol. 38, no. 6, pp. 311–319, 2003
  29. Improved MR Coronary Angiography with Use of a New Rapid Clearance Blood Pool Contrast Agent in Pigs
    Radiology, vol. 227, no. 3, pp. 802–808, 2003
  30. MR angiography with a new rapid-clearance blood pool agent: Initial experience in rabbits
    Magnetic Resonance in Medicine, vol. 48, no. 5, pp. 844–851, 2002
  31. Standardized MR protocol for the evaluation of MRA sequences and/or contrast agents effects in high-degree arterial stenosis analysis
    Magnetic Resonance Materials in Biology, Physics, and Medicine, vol. 14, no. 3, pp. 259–267, 2002
  32. P760A New Gadolinium Complex Characterized by a Low Rate of Interstitial Diffusion
    Academic Radiology, vol. 9, no. 1, pp. S17–S19, 2002
  33. Evaluation of MR Contrast Agents with High Relaxivity and Reduced Interstitial Diffusion for Contrast Material–enhanced MRA and Myocardial Perfusion Studies
    Academic Radiology, vol. 9, no. 1, pp. S88–S91, 2002
  34. Investigative Radiology, vol. 37, no. 7, pp. 368–375, 2002
  35. Arterial Concentration Profiles of Two Blood Pool Agents and Gd-DOTA after Intravenous Injection in Rabbits
    Academic Radiology, vol. 9, no. 1, pp. S137–S139, 2002
  36. Ultrasmall Superparamagnetic Iron Oxide–enhanced MR Imaging of Atherosclerotic Plaque in Hyperlipidemic Rabbits
    Academic Radiology, vol. 9, no. 1, pp. S143–S144, 2002
  37. CT Pulmonary Angiography and PerfusionAn Experimental Study using Blood Pool and Nonspecific Contrast Agent
    Academic Radiology, vol. 9, no. 2, pp. S359–S360, 2002
  38. MR Angiography with a New Rapid Clearance Blood Pool Agent (P792)Initial Experience in Rabbits
    Academic Radiology, vol. 9, no. 2, pp. S407–S408, 2002
  39. Effects of Ioxaglate on Cultured Microvascular Endothelial Cells Do All in Vitro Studies Actually Reflect Clinical Situations?
    Academic Radiology, vol. 9, no. 1, pp. 98–100, 2002
  40. Coronary magnetic resonance angiography: Experimental evaluation of the new rapid clearance blood pool contrast medium P792
    Magnetic Resonance in Medicine, vol. 46, no. 5, pp. 932–938, 2001
  41. A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: Kinetic study on a C6 rat glioma model
    Journal of Magnetic Resonance Imaging, vol. 14, no. 2, pp. 97–105, 2001
  42. Carboxymethyldextran-A2-Gd-DOTA enhancement patterns in the abdomen and pelvis in an animal model
    European Radiology, vol. 11, no. 7, pp. 1276–1284, 2001
  43. Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology
    Magnetic Resonance in Medicine, vol. 45, no. 5, pp. 880–886, 2001
  44. Investigative Radiology, vol. 36, no. 5, pp. 276–282, 2001
  45. Physicochemical and Biological Evaluation of P792, a Rapid-Clearance Blood-Pool Agent for Magnetic Resonance Imaging
    Investigative Radiology, vol. 36, no. 8, pp. 445–454, 2001
  46. Preclinical Profile of the Monodisperse Iodinated Macromolecular Blood Pool Agent P743
    Investigative Radiology, vol. 36, no. 1, pp. 41–49, 2001
  47. Comparison of plasma and peritoneal concentrations of various categories of MRI blood pool agents in a murine experimental pharmacokinetic model
    Magnetic Resonance Materials in Biology, Physics, and Medicine, vol. 12, no. 2-3, pp. 82–87, 2001
  48. CT Pulmonary Angiography with a Macromolecular Contrast Medium
    Investigative Radiology, vol. 36, no. 9, pp. 547–553, 2001
  49. P792: a rapid clearance blood pool agent for magnetic resonance imaging: preliminary results
    Magnetic Resonance Materials in Biology, Physics, and Medicine, vol. 12, no. 2-3, pp. 121–127, 2001
  50. Investigative Radiology, vol. 35, no. 1, p. 41, 2000
  51. Investigative Radiology, vol. 35, no. 4, pp. 213–218, 2000
  52. Kinetic characterization of CMD-A2-Gd-DOTA as an intravascular contrast agent for myocardial perfusion measurement with MRI
    Magnetic Resonance in Medicine, vol. 43, no. 3, pp. 403–409, 2000
  53. Physical, chemical, and biological evaluations of P760: A new gadolinium complex characterized by a low rate of interstitial diffusion
    Journal of Magnetic Resonance Imaging, vol. 11, no. 2, pp. 182–191, 2000
  54. Influence of the viscosity of iodixanol on medullary and cortical blood flow in the rat kidney: a potential cause of nephrotoxicity
    Journal of Applied Toxicology, vol. 19, no. 5, pp. 341–346, 1999
  55. Interference of magnetic resonance imaging contrast agents with the serum calcium measurement technique using colorimetric reagents
    Journal of Pharmaceutical and Biomedical Analysis, vol. 21, no. 5, pp. 931–943, 1999
  56. Investigative Radiology, vol. 34, no. 11, p. 663, 1999
  57. P760 and P775: MRI contrast agents characterized by new pharmacokinetic properties
    Magnetic Resonance Materials in Biology, Physics, and Medicine, vol. 8, no. 3, pp. 172–176, 1999
  58. Biometals, vol. 11, no. 2, pp. 113–123, 1998
  59. Structure-activity relationship of macrocyclic and linear gadolinium chelates: Investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme
    Journal of Magnetic Resonance Imaging, vol. 8, no. 3, pp. 695–702, 1998
  60. Pharmaceutical Research, vol. 14, no. 12, pp. 1713–1717, 1997
  61. Experimental Evaluation of the Vascular Effects and Transport of an Iodinated Macromolecular Contrast Medium
    INVESTIGATIVE RADIOLOGY, vol. 32, no. 8, pp. 447–452, 1997
  62. Angiography contrast agents interact with serine proteinases The molecular structure of the model system elastase/iohexol
    FEBS Letters, vol. 357, no. 3, pp. 247–250, 1995
  63. Involvement of protein solvation in the interaction between a contrast medium (iopamidol) and fibrinogen or lysozyme
    Biophysical Chemistry, vol. 54, no. 1, pp. 83–94, 1995
  64. Effect of Iodinated Contrast Media on Blood Clotting
    Investigative Radiology, vol. 24, no. 5, pp. 390–393, 1989
  65. Oxacillin and tobramycin serum levels during cardiopulmonary bypass
    Journal of Cardiothoracic Anesthesia, vol. 3, no. 2, pp. 163–167, 1989